Lauren Sabella

Chief Operating Officer at MANNKIND CORPORATION

Net worth: 2 M $ as of 31/05/2024

63 year

Health Technology

Consumer Services

Lauren Sabella active positions

Companies	Position	Start	End
MANNKIND CORPORATION	Chief Operating Officer	27/03/2023	-

Companies	Position	Start	End
ACORDA THERAPEUTICS, INC.	Chief Operating Officer	09/09/2021	30/09/2022
ACORDA THERAPEUTICS, INC.	Corporate Officer/Principal	25/01/2010	09/09/2021
Tugboat Consulting Group	Founder	01/01/2009	01/02/2010
Tugboat Consulting Group	Corporate Officer/Principal	01/01/2009	01/02/2010
Altus Pharmaceuticals, Inc. Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.	Corporate Officer/Principal	01/05/2006	30/09/2008
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Sales & Marketing	01/10/2002	01/04/2006

Hofstra University

Undergraduate Degree

International

United States

Operational

Corporate Officer/Principal	3
Chief Operating Officer	2
Undergraduate Degree	1

Sectoral

Health Technology	5
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
ACORDA THERAPEUTICS, INC.	Health Technology
MANNKIND CORPORATION	Health Technology

Private companies	3
Altus Pharmaceuticals, Inc. Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.	Health Technology
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology
Tugboat Consulting Group